Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 22497 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 450MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| BUPROPION HYDROCHLORIDE(UNII: ZG7E5POY8O) (BUPROPION - UNII:01ZG3TPX31) | BUPROPION HYDROCHLORIDE | 450mg |
Inactive Ingredients
| Ingredient Name | Edgemont Pharmaceuticals, LLC | Alvogen Inc. |
|---|---|---|
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM(K679OBS311) | ||
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED(K679OBS311) | ||
| COPOVIDONE K25-31(D9C330MD8B) | ||
| HYDROCHLORIC ACID(QTT17582CB) | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P) | ||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | ||
| MAGNESIUM STEARATE(70097M6I30) | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A(NX76LV5T8J) | ||
| METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER(NX76LV5T8J) | ||
| POLYETHYLENE GLYCOL 8000(Q662QK8M3B) | ||
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | ||
| POLYETHYLENE OXIDE 2000000(5K3991GVWI) | ||
| POLYVINYL ACETATE(32K497ZK2U) | ||
| POVIDONE K30(U725QWY32X) | ||
| SILICON DIOXIDE(ETJ7Z6XBU4) | ||
| STEARIC ACID(4ELV7Z65AP) | ||
| TALC(7SEV7J4R1U) | ||
| TITANIUM DIOXIDE(15FIX9V2JP) | ||
| TRIACETIN(XHX3C3X673) |
